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Abstract
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 causes hemorrhagic colitis and may result in potentially fatal hemolytic
uremia syndrome in humans. EHEC colonize the intestinal mucosa and promote the formation of actin-rich pedestals via
translocated type III effectors. Two EHEC type III secreted effectors, Tir and EspFu/TccP, are key players for pedestal
formation. We discovered that an EHEC effector protein called Non-LEE-encoded Ligase (NleL) is an E3 ubiquitin ligase. In
vitro, we showed that the NleL C753 residue is critical for its E3 ligase activity. Functionally, we demonstrated that NleL E3
ubiquitin ligase activity is involved in modulating Tir-mediated pedestal formation. Surprisingly, EHEC mutant strain
deficient in the E3 ligase activity induced more pedestals than the wild-type strain. The canonical EPEC strain E2348/69
normally lacks the nleL gene, and the ectopic expression of the wild-type EHEC nleL, but not the catalytically-deficient
nleL(C753A) mutant, in this strain resulted in fewer actin-rich pedestals. Furthermore, we showed that the C. rodentium NleL
homolog is a E3 ubiquitin ligase and is required for efficient infection of murine colonic epithelial cells in vivo. In summary,
our study demonstrated that EHEC utilizes NleL E3 ubiquitin ligase activity to modulate Tir-mediated pedestal formation.
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Introduction
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is an
important cause of food- and water-borne illnesses in developed
countries and in the world. EHEC O157:H7 infections cause
hemorrhagic colitis and can result in potentially fatal hemolytic
uremia syndrome [1,2,3]. EHEC along with Enteropathogenic E.
coli (EPEC) and Citrobacter rodentium form a group of pathogens
called A/E pathogens that are able to colonize the intestinal
mucosa and produce characteristic ‘attaching and effacing’ (A/E)
lesions. A/E lesions are characterized by effacement of the brush
border microvilli, intimate attachment of the bacterium to the
plasma membrane of the enterocytes, and the formation of actin-
rich pedestals within the host cell beneath the adherent bacteria
[4,5,6,7]. Pedestal formation requires virulence-related EHEC
proteins to be injected directly into the host cell through a type III
secretion system (TTSS) [8]. Two EHEC O157:H7 type III
secreted effectors, Tir and EspFu/TccP, are known to be required
for pedestal formation [9,10,11]. EspM was shown to inhibit
pedestal formation via an unknown mechanism [12,13].
Tir is a bacteria-made receptor that binds bacterial surface
protein intimin to facilitate the pedestal formation [14,15,16].
Binding to intimin is followed by coordinated events that lead to
rearrangement and/or assembly of actin to form pedestals on the
host cell surface. The N-terminus of the Tir domain binds several
host focal adhesion proteins, including a-actinin, talin and
vinculin, and cortactin to which may promote actin networks that
support the pedestal [17,18]. EHEC and EPEC Tir C-termini
appear to be modified by serine/threonine phosphorylation upon
entry into the host cell [19,20]. In addition, the C-terminus of
EPEC Tir is tyrosine phosphorylated, leading to the recruitment of
the host adaptor protein Nck, which in turn stimulates actin
assembly [21,22]. In contrast, EHEC Tir is not tyrosine
phosphorylated and does not recruit Nck. Instead, EHEC
translocates a second effector, EspFU/TccP, which co-localizes
with Tir at the site of EHEC attachment. EspFU activates N-
WASP by binding to its CDC42-binding domain [9,10,23].
Ubiquitination is a reversible posttranslational modification of
cellular proteins, in which a 76 amino acid polypeptide, ubiquitin,
is attached to the e-amino group of lysines in target proteins.
Ubiquitination is a major player in regulating a broad range of
cellular processes, including cell division, differentiation, signal
transduction, protein trafficking, and quality control [24,25].
Ubiquitination involves a multienzyme cascade consisting of
classes of enzymes known as ubiquitin-activating enzymes (E1),
ubiquitin-conjugating enzymes (E2) and ubiquitin protein ligases
(E3). The E3 ubiquitin ligases play pivotal roles in defining the
specificity of target proteins to be ubiquitinated. Most E3 ubiquitin
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the other possesses the RING finger domain [24]. The HECT
family E3 ubiquitin ligases contain a 350-residue region that
maintains a strictly conserved cysteine residue that is located
approximately 35 residues from the C-terminus [26,27]. Many
pathogenic microbes have developed means to interfere with
different stages of ubiquitin pathways to promote their survival
and replication. These include SopA, SlrP, SspH1, and SspH2
from Salmonella [28,29,30,31,32]; AvrPtoB from Pseudomonas syringae
[33,34,35]; IpaH 9.8 and IpaH3 from Shigella flexneri [31,36,37];
and LubX from Legionella pneumophila [38].
More than 60 putative EHEC type III effectors have been
proposed using the proteomic approach [39] and bioinformatic
studies [40]. Previous studies have suggested that the EHEC
EspX7 (ECs1560) as an type III effector [40,41,42]. EHEC EspX7
is predicted to encode a 782 amino acid peptide and is found on
prophage Sp6 [43]. EspX7 homolog is found in the closely related
A/E pathogen, C. rodentium [44] but not in EPEC E2348/69. We
report here that EspX7 is an E3 ubiquitin ligase with C753 being
critical for its ligase activity. This E3 ligase activity plays an
important role in down-modulating the pedestal formation. We
have renamed EspX7 as NleL (Non-Lee-Encoded effector Ligase)
to reflect its novel biochemical activity.
Results
Self-ubiquitination of GST-NleL
A study using a bioinformatic approach and validation with
various translocation assays has identified multiple translocated
effectors in EHEC including the NleL (ECs1560) locus [40]. A
sequence comparison and structural studies have identified NleL
as a bacterial HECT-like E3 ubiquitin ligase [28,30,45]. The
substrate and biological function of NleL remains unknown. Auto-
ubiquitination is often used in the absence of a physiological
substrate to measure the ubiquitin E3 ligase activity, we first tested
if GST-NleL has the E3 ligase activity in an in vitro auto-
ubiquitination assay using E1, E2 (UbcH5a), ATP, and ubiquitin
in the presence of purified recombinant GST-NleL
59–782.
Consistent with our previous work [45], poly-ubiquitinated
GST-NleL was observed by Western blot when E1, E2 or
ubiquitin were added to the reaction (Fig. 1A). No ubiquitination
of GST-NleL was detected in the absence of E1, E2 or ubiquitin,
indicating that each of these components were essential for GST-
NleL ubiquitination. Furthermore, the mutant GST-NleL
C753S
(pZP1658) or the GST-NleL
C753A (pZP2129) failed to form the
poly-ubiquitination pattern seen with the wild-type GST-NleL in
the in vitro ubiquitination assay (Fig. 1B). To assess the specificity
of the cysteine mutation, a substitution mutant targeting C688
(C688S, pZP1657) of NleL was used in the same ubiquitination
assay. Western blot analysis shows presence of mono- and poly-
ubiquitinated GST-NleL
C688S species similar to those observed
when the wild-type GST-NleL was used (Fig. 1B).
Mutant NleL
C753A is translocated at similar efficiency as
the wild-type NleL into mammalian host cells
To test whether NleL
C753A mutant affected the secretion of
other type III effectors, we examined the secretion of Tir, a key
player in EHEC-mediated actin pedestal formation upon
infection. The expression and secretion levels of Tir in EHEC
expressing the chromosomal catalytically-dead mutant NleL
C753A
(ZP254) was found to be similar to that of the wild type EHEC
(Fig. 2A). Previous studies have shown that NleL (EspX7) might
be a type III EHEC effector [40,41,42]. We further tested whether
NleL was translocated using an adenylate cyclase (CyaA) reporter
system [46]. The CyaA from B. pertussis requires host cell derived
calmodulin for its activity, hence fusion proteins of CyaA only with
proteins that translocate into the host cell have catalytic activity
which can be examined by measuring cAMP levels. We compared
cAMP levels from HeLa cells infected with either the wild-type
strain (ZP250) or a TTSS-deficient EHEC strain (escF, ZP251),
both harboring the reporter plasmid expressing NleL-CyaA in-
frame fusion (pZP1671). Cells infected with the wild-type EHEC
strain show approximately 400-fold higher cAMP levels as
compared to those infected with the TTSS-deficient strain
(Fig. 2B). These results confirmed that NleL is indeed an effector
protein translocated via the EHEC O157:H7 type III-secretion
system.
Similarly, we tested the translocation of NleL
C753A using the
cyaA reporter gene assay. HeLa cells were infected with wild-type
EHEC harboring the plasmid encoding either the wild type NleL-
CyaA, or the NleL
C753A-CyaA fusion protein. We found that the
cAMP levels were similar to those detected in cells infected with
Salmonella harboring the wild-type NleL. This indicates that the
C753A mutation did not significantly alter the translocation of
NleL (Fig. 2). Expression of the wild-type and the C753A mutant
NleL-CyaA fusion proteins in bacterial whole cell lysates was
further confirmed to be at similar levels by Western analysis
(Fig. 2, lower panel).
E3 ligase activity of NleL down-regulates the EHEC
pedestal formation
A central function of the EHEC translocated effectors is to
promote pedestal formation, which is a hallmark of A/E
pathogens [47]. Pedestals are actin-rich structures formed as a
direct result of effectors that bring about cytoskeletal rearrange-
ments upon translocation by the EHEC TTSS [23]. Two EHEC
effectors, Tir and EspFu are sufficient to induce the formation of
pedestals [9,10,17,48,49]. To test whether the ligase activity of
NleL is involved in pedestal formation, an EHEC strain expressing
the chromosomal catalytically-dead mutant NleL
C753A was used to
infect HeLa cells to examine its ability to form pedestals. The
number of pedestals formed in HeLa cells infected with ZP254 was
increased significantly as compared to those in cells infected with
the wild-type ZP250 (Fig. 3). For example, the percentage of cells
with no pedestals decreased two-fold, and the percentage with
more than 10 pedestals increased more than two-fold. The
phenotype of ZP254 infected HeLa cells could be rescued by
introducing wild-type NleL expressing plasmid (pZP1666) into
ZP254. Together, these data indicate that the E3 ligase activity of
NleL plays a major role in down-regulating pedestal formation
during EHEC infection.
The E3 ligase activity of EHEC NleL down modulate EPEC
pedestal formation
A genome-wide search of the A/E pathogens revealed that
EPEC strains do not harbor the nleL gene. We showed that the E3
ligase activity of NleL down modulates the pedestal formation
during EHEC infection. Unlike EHEC, canonical EPEC strains
do not encode EspFU, and generate pedestals by recruiting the
host adaptor Nck after phosphorylation of a tyrosine residue in the
Tir C-terminus, one that is lacking in EHEC Tir [21,22]. To
determine if, in spite of this mechanistic difference, EHEC NleL
also acts to diminish pedestal formation during EPEC infection,
we introduced EHEC NleL into the wild-type EPEC strain and
assessed their ability to form pedestals. As shown in Fig. 4,a n
EPEC strain expressing the wild type EHEC NleL induced
significantly less pedestals compared to that induced by the wild-
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NleL
C753A. For example, the percentage of cells with no pedestals
was ,10-fold higher when wild type NleL was delivered. This
result suggests that rather than diminish a process specific to Nck
or EspFU the E3 ligase activity of NleL functions to down
modulate a common step of pedestal formation by EPEC and
EHEC.
C. rodentium NleL is an E3 ligase and is essential for C.
rodentium virulence in mice
The efficiency of pedestal formation may influence the bacterial
colonization and/or degree of inflammation during natural
infection. C. rodentium has been used as a model microorganism to
assess the virulence of the A/E pathogens in the mouse infection
model. To evaluate whether NleL plays a role in an animal model,
we first determined if C. rodentium NleL has E3 ligase activity in an in
vitro ubiquitination assay using the in vitro auto-ubiquitination assay.
GST-NleL
59–782 was added as the potential E3 ligase. Western
blotting with either GST or ubiquitin antiserum shows the presence
of mono and poly-ubiquitinated C. rodentium NleL (Fig. 5A). No
ubiquitination of C. rodentium NleL was observed when GST-
NleL
C753S was used or in the absence of E1 or UbcH5a indicating
that each of these components of the ubiquitination reaction is
required for the ubiquitination of NleL. This indicates that C.
rodentium NleL is an E3 ubiquitin ligase and C753 is essential for the
ligase activity. We next determined if C. rodentium NleL plays a role
in C. rodentium virulence in a murine infection model.
C. rodentium infection in C57BL/6 mice is characterized by loose
stool progressing to diarrhea in severe cases, poor overall body
condition, and weight loss, which can be fatal particularly in young
animals [50,51]. Colonic lesions consist of epithelial hyperplasia,
submucosal edema, mucosal erosion and ulceration, and inflam-
matory infiltration varying from submucosal to transmural
[50,52]. As shown in Fig. 5B, fecal bacteria shedding of the
wild-type strain (DBS130) of C. rodentium reached a maximum at 6
days post-inoculation (DPI) of 6610
8 CFU/g of feces in
agreement with previous reports of C. rodentium infection of
C57BL/6J mice [52,53,54]. Fecal shedding of the C. rodentium nleL
null mutant strain (DBS792), the nleL mutant strain expressing the
wild-type C. rodentium NleL (DBS793), or the nleL mutant strain
complemented with the catalytically-dead NleL
C753S (DBS794)
were comparable to the wild-type C. rodentium by 6 DPI and
remained comparable until sacrifice at 13 DPI (Fig. 5B).
In spite of the observation that NleL had no significant effect on
colonization, this effector promoted disease. By 12 DPI uninoc-
ulated mice had gained 8% of their initial body weight, whereas
mice inoculated with either the wild-type or nleL complemented
strain had significant weight loss (8% and 3% of initial weight by
12 DPI, P,0.001, Fig. 5C). In contrast, mice inoculated with the
nleL mutant or the non-complementing point mutant NleL
C753S
gained weight (5% and 4%, respectively) and were not significantly
different from uninoculated mice throughout the study. In
addition, infection with wild-type C. rodentium resulted in robust
colitis with multifocal erosions, infiltration of neutrophils, lym-
phocytes and macrophages, hyperplasia, and herniation of glands
into local lymphoid tissue. At 13 DPI the histologic colitis index
was comparable between mice inoculated with either wild-type
strain (median index of 13.25 [13.0 to 14.0]) or nleL-complement-
ed strain (10.0 [7.0 to 16.5]) of C. rodentium (Fig. 5D). Deletion of
nleL from C. rodentium resulted in reduced lesion severity and colitis
in mice (8.5 [8.0–10.0]) compared to wild-type inoculated mice
(P,0.05). Similarly, inoculation with the non-complementing
NleL
C753S point mutant resulted in less severe colitis than wild-
type C. rodentium (P,0.01) with a histologic colitis index of 7.0 (5.0–
10.5) that was statistically indistinguishable from the nleL mutant.
Discussion
EHEC and EPEC are members of the Attaching and Effacing
pathogen group of organisms that cause serious food- and water-
borneillnessesinhumans.ApathogenicinfectionbyEHECorEPEC
involves attachment of the pathogen to the surface of the host cell
followed by translocation of key effector proteins into the cytoplasm
via the TTSS. Although the molecular events that follow differ
somewhat between EHEC and EPEC, they result in the rearrange-
ments of host cytoskeletal machinery, which in turn leads to the
formation of morphologically similar pedestals, a hallmark of an A/E
pathogenic infection. Although a considerable amount of research on
Figure 1. Self-ubiquitination of GST-NleL. (A) NleL-mediated self-ubiquitination requires ATP, ubiquitin, E1 and E2. Combinations of ATP,
ubiquitin, E1, UbcH5a and GST-NleL
59–782 were incubated at 35uC for 90 min, and the Western blot was performed using polyclonal anti-ubiquitin
antibodies (top) or anti-GST antibodies (bottom). (B) NleL C753 residue is required for its E3 ubiquitin ligase activity. Reactions containing ubiquitin,
E1 and UbcH5a were incubated with the wild type GST-NleL, GST-NleL
C688S or GST-NleL
C753S or GST-NleL
C753A at 35uC for 90 min. The Western blot
was performed using monoclonal anti-ubiquitin antibodies (top) or anti-GST antibodies (bottom).
doi:10.1371/journal.pone.0019331.g001
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known about how this process is regulated. We demonstrated here
that EHEC utilize the host ubiquitination pathway to down-regulate
the pedestal formation, perhaps to maintain a balance to co-exist with
the host cells. Thus, the bacteria is involved actively not only in the
formation, but also the modulation of pedestal formation. Consistent
with the hypothesis that unregulated pedestal formation may alter
disease, we demonstrate the importance of NleL and its E3 ubiquitin
ligase activity in development of clinical and pathological disease
caused by C. rodentium.
EHEC NleL shares sequence similarity to Salmonella SopA mainly
toward the C-terminus where the E3 ligase activity lies [28,30]. A
recent study found that both NleL and SopA form the bilobed
catalytic domain reminiscent of the N- and C-lobe architecture of
HECT E3 ligases [45]. Although both NleL and SopA possess poly-
ubiquitination activities in vitro, NleL form free (unanchored) poly-
ubiquitin chains when the GST-free NleL is used in the
ubiquitination assay [45]. Salmonella is able to invade the host cells
and survive inside the host cells. In contrary, EHEC exerts its
virulence by adhering to the surface of the host cells via actin-rich
pedestals. It is not clear whether the different biochemical E3 ligase
activities contribute to the different life-style of the two intestinal
pathogens. We speculate that NleL may exploit the free ubiquitin
pools in the host cell to exert its function without the canonical
substrates. Further studies are needed to examine this possibility.
Our data demonstrate that loss of the NleL E3 ligase activity
leads to increased pedestal formation. Preliminary work showed
that the loss of the NleL E3 ligase activity did not alter the
expression of Tir or EspFu (Fig. 2A and data not shown),
suggesting that NleL may exert its function after their transloca-
tion. EPEC infection has been shown to lead to pedestal formation
much more efficiently than that of EHEC in vitro [55]. A significant
difference between the two pathogenic types lies in the nature of
the involvement of Tir during pedestal formation. While TirEPEC
is tyrosine phosphorylated upon entry into the host cell and
interacts with host adaptor protein Nck, which stimulates Arp2/3-
mediated actin polymerization [49,56], TirEHEC lacks the
homologous tyr residue, Y474, and depends on another effector
EspFu/TccP to induce actin polymerization [9,10,23]. Such
studies highlight the differences in the mechanism of pedestal
formation between the two organisms. Our data indicate that
NleL probably functions at steps common to EPEC and EHEC-
mediated pedestal formation. It is reasonable to speculate that
NleL ubiquitinates an unknown factor of bacterial or host origin
involved in pedestal formation. One such scenario would be that
host cell proteins involved in pedestal formation are ubiquitinated
by NleL which, in turn, corresponds to a decrease in the level of
host proteins or alters their localization, resulting in a decrease in
pedestal formation. Alternatively, NleL may ubiquitinate Tir and
promote its endocytosis, thus decreasing the surface availability of
Tir. Our preliminary studies have shown that Tir is not a substrate
for the E3 ligase activity of NleL in an in vitro ubiquitination assay
(data not shown). However, we cannot rule out that a third factor
is required, but absent, in our in vitro reaction. A recent structural
study showed that another non-LEE-encoded effector, NleG, is a
RING finger ubiquitin E3 ligase [57]. It is tempting to speculate
that NleL, NleG and Tir may work together to modulate the actin
pedestal formation. In addition, Tir is inserted into the plasma
membrane of the host cell in a hairpin loop structure. It is also
possible that NleL is affecting Tir localization. Further studies are
required to dissect the exact molecular mechanism on how the E3
ligase activity of NleL modulates the pedestal formation.
Materials and Methods
Bacterial strains, plasmids and mammalian cell lines
The Enterohemorrhagic strain designated E. coli O157:H7
(ZP250), a spontaneous nalidixic acid mutant of an outbreak strain
isolated from apple juice (RM1484) [58,59]. Using ZP250 as a
parent, strains harboring in-frame chromosomal deletions of genes
escF (ZP251) were generated with the help of an allelic-exchange
suicide vector as described previously [60]. The EHEC strain
expressing mutant NleL
C753A (ZP254) was generated similarly using
a plasmid encoding the NleL
C753A (pZP2111). C. rodentium nleL null
deletion strain was similarly generated. Complementing strains were
created by introducing the plasmid expressing the wild-type C.
rodentium NleL (pZP1661) or the catalytically-dead NleL
C753S
(pZP1664) into DBS792 generating DBS793 and DBS794 respec-
tively. The EHEC nleL-M45 complementation plasmid (pZP1666)
was constructed by cloning DNA fragments encoding full length
NleL and its promoter sequence (250 bp upstream of the translation
start site) into pSB1136, a pBAD derivative [61]. The nleL
translocation plasmid (pZP1671) was subcloned by ligating nleL
DNA sequences from the complementation plasmid with appropri-
Figure 2. Secretion of Tir and translocation of NleL into HeLa
cells. (A) The expression and secretion levels of Tir in either the wild-
type EHEC or the mutant EHEC expressing the chromosomal
catalytically-dead mutant NleL
C753A was examined by Western blot.
(B) Intracellular cAMP levels are an indication of the translocation of
CyaA fusion proteins in EHEC WT (ZP250) and EHEC TTSS deficient
mutant (escF; ZP2251) strains. Cells were infected for 4 hrs, and the
adenylate cyclase activity was determined. The data were from three
independent experiments, with standard deviations shown as error
bars. cAMP values are presented as pmol per milligram of total cellular
protein. The expression levels of the NleL-CyaA fusions were found to
be similar by Western blot as shown on the bottom panel.
doi:10.1371/journal.pone.0019331.g002
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tagged EHEC Tir complementation was previously described [9].
The plasmid expressing amino acid residues 59 through 782 of NleL
(NleL
59–782) as a fusion protein with glutathione S-transferase (GST)
was constructed by subcloning the relevant nleL coding sequence into
pGEX-KG (pZP1173) [63]. Single base substitution mutations
changing residues either C688 (pZP1667) or C753 (pZP1668) to
Serine or Alanine were introduced using the Quick-Change Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA) according to the
manufacturer’s protocol. The plasmid expressing C-terminal 6xHis-
epitope tagged Tir (pZP1517) was constructed by cloning Tir coding
sequence into pET28a (EMD Biosciences, Madison, WI).
HeLa cells from ATCC Cell Biology Stock Center (Manassas,
VA), were grown in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal calf serum (Gibco, Carlsbad, CA,
USA).
Purification of recombinant proteins from E. coli
Recombinant fusion proteins, GST-NleL and Tir-6XHis were
purified from E. coli BL21(DE3) harboring respective plasmids
using glutathione- Sepharose 4B (Amersham Biosciences, Piscat-
away, NJ) and Ni-NTA resin (Qiagen, Valencia, CA), respectively.
All purified proteins were dialyzed and resuspended in phosphate-
buffered saline (PBS) containing 2 mM dithiothreitol.
Figure 3. E3 ligase activity of NleL is involved in modulating EHEC pedestal formation. HeLa cells were infected at a multiplicity of
infection of 100 with wild type EHEC, nleL
C753A,o rnleL
C753A harboring plasmid expressing wild-type NleL. Cells were infected for 6 hours. (A) Bacteria
were visualized by staining with an anti-EHEC LPS antibody (green). Actin was detected with a Texas Red Phalloidin (red). (B) The number of micro-
clusters of pedestals on HeLa cells were counted and were grouped into clusters having 1–4 pedestals, 5–10 pedestals and .10 pedestals.
Quantitative analysis includes three independent experiments. A minimum of 300 cells were counted from each experiment with standard deviation
shown as error bars.
doi:10.1371/journal.pone.0019331.g003
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EHEC strains were grown overnight standing at 37uC in Luria-
Bertani (LB) broth supplemented with nalidixic acid (50 mgml
21)a n d
used directly for infection [20]. EPEC strains were grown overnight
standing at 37uC in LB supplemented with followed by subculture
(1:100) in Hepes-buffered DMEM until optical density of the cultures
measured at 600 nm reached 0.7 [9]. Cultures were then used to
infect HeLa cells grown in 24-well tissue culture plates at 37uCi n5 %
CO2 with 10% fetal calf serum (Gibco, Carlsbad, CA, USA), at a
multiplicity of infection (moi) of 100, unless specified otherwise.
Figure 4. The E3 ligase activity of EHEC NleL down modulates EPEC pedestal formation. HeLa cells were infected at a multiplicity of
infection of 100 with wild type EPEC, or EPEC harboring plasmid expressing wild-type EHEC NleL or NleL
C753A. Cells were infected for 4 hours.
(A) Bacteria were visualized by staining with an anti-EPEC LPS antibody (green). Actin was detected with a Texas Red Phalloidin (red). (B) The number
of micro-clusters of pedestals on HeLa cells were counted and were grouped into clusters having 1–10 pedestals, 11–20 pedestals and .20 pedestals.
Quantitative analysis includes three independent experiments. A minimum of 300 cells were counted from each experiment with standard deviation
shown as error bars.
doi:10.1371/journal.pone.0019331.g004
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Bacterial strains were grown overnight in LB at 37uC. The
cultures were then diluted 1:20 in M-9 minimal media
supplemented with 0.4% glucose, 8 mM MgSO4,4 4 m M
NaHCO2, and 0.1% Casamino Acids and grown standing at
37uCi n5 %C O 2 until the OD600 reached approximately 0.8. The
bacterial cultures were centrifuged and the supernatants were
filtered through a 0.22 um filter to remove any residual bacteria.
Proteins in the supernatants were precipitated with 10%
trichloroacetic acid on ice for at least 1 hour. Precipitated proteins
were collected by centrifugation and washed twice with ice-cold
acetone before being resuspended in SDS-PAGE loading buffer.
Adenylate cyclase translocation assay
HeLa cells were infected as described. Four hours post-
infection, cells were washed with ice-cold PBS and lysed using
0.1 M HCl with gentle agitation for 20 min. Protein concentration
in cell lysates was determined using the Bio-Rad Protein Assay Kit
(Hercules, CA) according to the manufacturer’s instructions. Equal
amount of protein was used to determine levels of Adenosine 39,
59-cyclic monophosphate (cAMP) using the Direct Immunoassay
Kit (Assay Designs, MI) according to the manufacturer’s
instructions. Adenylate cyclase activity is expressed as pmol per
milligram of total protein.
Figure 5. Contribution of nleL to C. rodentium virulence. (A) C. rodentium NleL is an E3 ubiquitin ligase. Combinations of ATP, ubiquitin, E1,
UbcH5a and GST-NleL or GST-NleL
C753S were incubated at 35uC for 90 min, and the Western blot was performed using polyclonal anti-ubiquitin
antibodies (top) or anti-GST antibodies (bottom). (B) Fecal bacteria shedding of the wild-type strain (DBS130), the nleL null mutant strain, the nleL
mutant strain expressing the wild-type NleL, or the nleL mutant strain complemented with the catalytically-dead NleL
C753S in C. rodentium.( C)
Virulence of C. rodentium strains as indicated by weight of the mice post-inoculation. The percent weight change of the mice over the 13 days post-
inoculation was measured. The error bars indicate standard errors. Mice infected with nleL deletion strain (DBS792) had significantly reduced weight
loss when compared to the wild type (DBS130). This could be partially rescued by plasmid expressing the full length NleL (DBS793) but not by
plasmid expressing the catalytically inactive NleL
C753S mutant (DBS794). (D) Contribution of nleL to mouse colitis caused by C. rodentium. Pathology
of mouse colon by different C. rodentium strains, as indicated by histologic activity index (sum of lesion scores). At day 13 post-inoculation colon
tissue was scored for lesions: inflammation, edema, epithelial defects, crypt atrophy, hyperplasia, and dysplasia. Mice infected with nleL deletion strain
showed significantly reduced lesions when compared to the wild type (P,0.05). This could be rescued by plasmid expressing the full length NleL but
not by plasmid expressing the catalytically inactive NleL
C753S mutant (P,0.01).
doi:10.1371/journal.pone.0019331.g005
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HeLa cells infected for 3 hours were maintained in fresh media
for an additional 3 hours. Cells were washed with cold PBS, fixed
in 3% formaldehyde and permeabilized with 0.1% Triton X-100
[4]. Cells were incubated with either rabbit anti-O antibody
(EHEC O157, Difco Laboratories, Detroit, MI; EPEC O111,
Denka Seiken Co., Tokyo, Japan) as primary and Alexa Flour 488
conjugated anti-rabbit (1:300 dilution) secondary antibody or
Texas-red Phalloidin (1:300; Molecular Probes, Carlsbad, CA). All
images represent black and white projections of z-section slices
obtained on a Zeiss LSM 700 confocal microscope. Approximately
300 cells were counted from each infection. Based on the number
of pedestals per cluster, the clusters were divided into groups; extra
large cluster (.20 pedestals/cluster for EPEC), large clusters (.10
pedestals/cluster), medium clusters (6–10 pedestals/cluster) and
small clusters (1–5 pedestals/cluster).
In vitro ubiquitination assay
In vitro ubiquitination experiments were carried out as described
[64]. Briefly, a reaction mixture containing 40 mM Tris-HCl,
pH 7.5, 5 mM MgCl2, 2 mM ATP, 2 mM dithiothreitol, 300 ng/
ml ubiquitin [65], 0.1 mM E1 activating enzyme, 0.5 mM UbcH5a,
E2 ubiquitin-conjugating enzyme (Boston Biochem, Boston, MA),
2 mg GST-NleL, GST-NleL
C688S, GST-NleL
C753S, or GST-
NleL
C753A were incubated at 35uC for 90 min and subjected to
SDS-PAGE (8%) and Western blot analysis using anti-GST or
anti-MBP antibodies (New England Biolabs, Ipswich, MA). A
similar in vitro ubiquitination assay was performed for each of the
E2 ubiquitin-conjugating enzymes of interest: UbcH2, UbcH3,
UbcH5a, UbcH5b, UbcH5c, UbcH6, UbcH7 and UbcH10
(Boston Biochem, Boston, MA).
Mice Infection
Female 5-week old C57BL/6J (The Jackson Laboratory, Bar
Harbor, Maine) mice were fed a rodent diet and water ad libitum
and housed in micro-isolator cages that were maintained specific-
pathogen-free of known murine bacterial, viral and parasitic
infections including all known Helicobacter spp. in facilities at MIT
approved by the Association for Assessment and Accreditation of
Laboratory Animal Care, International. Mice were divided into
five groups and gavaged with ,2610
9 of an overnight culture of
the wild-type C. rodentium DBS130 (n=4), the nleL null mutant
strain DBS792 (n=6), the nleL mutant strain expressing the wild-
type NleL DBS793 (n=6), or the nleL mutant strain complement-
ed with the catalytically-dead NleL
C753S DBS794 (n=6) in 100 ml
PBS. Uninoculated mice were gavaged with 100 ml sterile PBS
(n=4). C. rodentium fecal shedding was monitored by serial dilution
plating of fecal slurries on MacConkey agar with selection for
nalidixic acid or chloramphenicol. Body weights of individual mice
were monitored and mice sacrificed at 2 WPI. At necropsy, colon
was collected, fixed in 10% formalin, paraffin embedded,
sectioned at 5 mm, and stained with hemoxylin and eosin for
histologic evaluation. Colonic tissue sections were scored on a scale
of 0–4 (where 0 = no lesion, 1 = minimal, 2 = mild, 3 =
moderate, and 4 = severe) for inflammation, edema, hyperplasia,
dysplasia, epithelial defects, and crypt atrophy by a board-certified
blinded pathologist. Lesion scores are presented as histologic
activity indices that are a sum of all six categorical scores
(maximum of 24). Bacterial shedding and weight change were
analyzed by two-way ANOVA with Bonferroni post-test. Histo-
logic colitis indices were evaluated by one-way ANOVA with
Dunnett’s post-test compared to DBS130.
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